Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
EZ Cap™ Cy5 EGFP mRNA: Assay Design Guide
2026-09-09
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) combines Cy5-labeled mRNA tracking with EGFP expression to separate cellular delivery from translation. This guide applies the reporter to LNP heterogeneity, assay controls, and structure–function decisions beyond conventional transfection readouts.
-
Doxorubicin Workflows for Senescence Assays
2026-09-09
Use Doxorubicin as a controlled DNA-damage and apoptosis benchmark when testing senolytic or senomorphic candidates. This workflow connects oncology-grade assay rigor with the Lactobacillus plantarum DS0037 nanovesicle findings while preserving the distinction between selective cell killing and SASP modulation.
-
Goat anti-rabbit IgG secondary antibody workflow
2026-09-08
Build reproducible red-channel detection into plaque biology, cell imaging, tissue pathology, flow cytometry, and ELISA workflows with a fluorophore-conjugated secondary antibody. The HyperFluor™ 594 format combines broad rabbit IgG recognition with application-specific dilution guidance and practical storage safeguards.
-
Designing Better mRNA Reporter Assays
2026-09-08
A mechanistic and translational guide to using Cap1, m1Ψ-modified Firefly Luciferase mRNA for separating delivery, translation, cell health, and expression kinetics while interpreting new evidence on synthetic mRNA fidelity.
-
Trilaurin (Glycerol Tridodecanoate) Protocol Guide
2026-09-07
Trilaurin (Glycerol Tridodecanoate, SKU BA7536) is a water-insoluble C12 triacylglycerol used as a lipid excipient, formulation component, and biocatalytic synthesis substrate. This guide covers solvent selection, short-term handling, particle-formulation workflows, and enzyme-reaction QC while defining why it should not be treated as a direct aqueous reagent or routinely stored as a long-term solution.
-
Fluorescein Tyramide in Translational Neuroscience
2026-09-07
This thought-leadership article connects recent evidence on early life adversity, oxytocin signaling, and superior colliculus circuitry with practical assay strategy. It explains how Fluorescein Tyramide can support sensitive IHC, ISH, and flow cytometry workflows while distinguishing literature findings from proposed validation steps.
-
NMDA for Excitotoxicity Assay Design
2026-09-05
NMDA (N-Methyl-D-aspartic acid) provides a direct, controllable trigger for receptor-mediated calcium loading and excitotoxic injury. This practical workflow connects concentration scouting with ferroptosis-aware readouts for retinal ganglion cell and neurodegenerative disease models.
-
Aneugen Mechanisms Revealed by Flow Cytometry
2026-09-04
Bernacki and colleagues developed a tiered assay that combines DNA-damage biomarkers, Taxol-associated fluorescence, phospho-histone H3, Ki-67, clustering, and machine learning to distinguish major aneugenic mechanisms. The workflow provides a mechanistic complement to micronucleus testing by separating tubulin stabilization, tubulin destabilization, and mitotic kinase inhibition in TK6 cells.
-
Amikacin disulfate: Mechanism Study Workflows
2026-09-04
Amikacin disulfate supports more than routine antibacterial screening: it can connect 16S rRNA-centered mechanism studies with orthogonal protein-binding and activity assays. This workflow-driven guide shows how to prepare the compound, validate assay signals, investigate lysozyme complexation, and troubleshoot instability or misleading readouts.
-
Annexin V-Cy5: Separating Apoptosis from Lysosomal Stress
2026-09-03
In zebrafish microglia, mestranol can impair lysosomal digestion without increasing neuronal apoptosis. This thought-leadership guide explains how Annexin V-Cy5 apoptosis detection can serve as a mechanistic checkpoint, helping translational researchers distinguish phosphatidylserine exposure and true cell death from cargo accumulation, altered lysosomal function, and imaging artifacts.
-
Nicotinamide Riboside Chloride in RGC Research
2026-09-03
Nicotinamide Riboside Chloride (NIAGEN) provides a practical way to test NAD+ metabolism in chemically defined retinal ganglion cell models. This article connects the compound’s metabolic applications with an efficient iPSC-to-RGC workflow while separating established evidence from proposed experimental extensions.
-
Targeted Amikacin Delivery into Mycobacterial Granulomas
2026-09-02
The reference study developed a cell-based strategy to transport fluorescently labeled amikacin into Mycobacterium avium granulomas in infected mice. Its central contribution is a proof of targeted delivery using primed dendritic cells, while preserving measurable antimycobacterial activity and avoiding detectable increases in selected inflammatory markers.
-
Cy3 Goat Anti-Human IgG (H+L) Antibody Workflow
2026-09-02
Build sensitive human IgG detection workflows for immunofluorescence, tissue imaging, flow cytometry, and ELISA with a Cy3-conjugated secondary antibody. Practical controls, optimization ranges, and troubleshooting guidance help connect antibody-binding assays with translational orthopoxvirus research without confusing detection with neutralization.
-
Cy3 Goat Anti-Human IgG (H+L) Antibody Workflow
2026-09-01
Build sensitive human-IgG detection workflows for immunofluorescence, tissue imaging, flow cytometry, and fluorescent ELISA with a Cy3 conjugated secondary antibody. This guide also explains how to translate antibody-characterization insights from orthopoxvirus research into better assay controls without confusing a detection reagent with an antiviral therapeutic.
-
Inflammation in Ischemic Stroke: Biomarkers to Treatment
2026-09-01
The 2025 Frontiers in Immunology review by Xiao et al. integrates inflammatory mechanisms, biomarker applications, and treatment research in ischemic stroke. Its main value is a time- and compartment-aware framework that connects blood–brain barrier disruption, central and peripheral immunity, diagnostic interpretation, and therapeutic development while emphasizing the limits of current evidence.